Notice2026-00999
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 20, 2026
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 12 (Tuesday, January 20, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 12 (Tuesday, January 20, 2026)]
[Notices]
[Pages 2358-2359]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-00999]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-26-0009]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Disease Surveillance Program--I.
Case Reports'' to the Office of Management and Budget (OMB) for review
and approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on July 28,
2025, to obtain comments from the public and affected agencies. CDC
received three comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the
[[Page 2359]]
functions of the agency, including whether the information will have
practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a> Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Disease Surveillance Program--I. Case Reports (OMB Control
No. 0920-0009, Exp. 1/31/2026)--Revision--National Center for Emerging
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Surveillance of the incidence and distribution of disease has been
an important function of the US Public Health Service (PHS) since the
1878 Act of Congress authorized the PHS to collect morbidity reports.
After the Malaria Control in War Areas Program had fulfilled its
original 1942 objective of reducing malaria transmission, its basic
tenets were carried forward and broadened by the formation of the
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a
well-equipped, broadly staffed agency used to translate facts about
analysis of morbidity and mortality statistics on communicable diseases
and through field investigations.
It was soon recognized that control measures (such as the DDT
spraying for malaria) did not alleviate the threat of disease
reintroduction. In 1950, the Malaria Surveillance Program began and in
1952, the National Surveillance Program started. Both programs were
based on the premise that diseases cannot be diagnosed, prevented, or
controlled until existing knowledge is expanded and new ideas developed
and implemented. The original scope of the National Surveillance
Program included the study of malaria, murine typhus, smallpox,
psittacosis, diphtheria, leprosy, and sylvatic plague. Over the years,
the mandate of CDC has broadened in preventive health activities and
the surveillance systems maintained have expanded. This program is
authorized under the Public Health Service Act, Section 301 and 306 (42
U.S.C. 241 and 242K).
This data collection covers surveillance activities for four, rare
diseases: (1) Creutzfeldt-Jakob Disease (CJD); (2) Reye Syndrome; (3)
Kawasaki syndrome; and (4) Acute Flaccid Myelitis. Data will be used
for planning and evaluating effective programs for prevention and
control of these infectious diseases. Disease incidence is needed to
study present and emerging disease problems and the surveillance data
serves as statistical material for those engaged in research or medical
practice, aid to health education officials and students, and data for
manufacturers of pharmaceutical products. Annual surveillance data are
published in the MMWR Surveillance Summary. Case data will be
transmitted to CDC electronically or hard copy from State and Local
Health Departments.
This Revision is submitted to renew the data collection package for
an additional three years and to update the Acute Flaccid Myelitis
format for collecting race and ethnicity. CDC requests OMB approval for
an estimated 98 annual burden hours. There is no cost to respondents
other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Epidemiologist........................ Creutzfeldt-Jakob 10 2 20/60
Disease (CJD).
Reye Syndrome........... 1 1 20/60
Kawasaki syndrome....... 20 2 15/60
Acute Flaccid Myelitis.. 60 2 30/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2026-00999 Filed 1-16-26; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on January 20, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.